Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia

Affiliations

25 February 2022


Abstract

Avoidant/Restrictive Food Intake Disorder and misophonia seem to be overrepresented in autism spectrum disorder. Literature is mute on psychopharmacotherapy in these complex presentations. Here, authors report on a challenging case of low-functioning ASD child with comorbid ARFID and misophonia that responded favorably to a low-dose risperidone. This is followed by a brief discussion of purported pharmacodynamic mechanisms and relevant literature.

Keywords: ARFID; ASD; misophonia; risperidone.


Similar articles

Eating behaviour, behavioural problems and sensory profiles of children with avoidant/restrictive food intake disorder (ARFID), autistic spectrum disorders or picky eating: Same or different?

Dovey TM, Kumari V, Blissett J; Mealtime Hostage Parent Science Gang.Eur Psychiatry. 2019 Sep;61:56-62. doi: 10.1016/j.eurpsy.2019.06.008. Epub 2019 Jul 13.PMID: 31310945

Avoidant/Restrictive Food Disorder (ARFID), Food Neophobia, Other Eating-Related Behaviours and Feeding Practices among Children with Autism Spectrum Disorder and in Non-Clinical Sample: A Preliminary Study.

Kozak A, Czepczor-Bernat K, Modrzejewska J, Modrzejewska A, Matusik E, Matusik P.Int J Environ Res Public Health. 2023 May 14;20(10):5822. doi: 10.3390/ijerph20105822.PMID: 37239549 Free PMC article.

Delayed avoidant restrictive food intake disorder diagnosis leading to Ogilvie's syndrome in an adolescent.

Bertrand V, Dhenin C, Déchelotte P, Faerber M.Eat Weight Disord. 2022 Jun;27(5):1913-1918. doi: 10.1007/s40519-021-01315-0. Epub 2021 Oct 8.PMID: 34623607 Review.

Avoidant/restrictive food intake disorder and severe food selectivity in children and young people with autism: A scoping review.

Bourne L, Mandy W, Bryant-Waugh R.Dev Med Child Neurol. 2022 Jun;64(6):691-700. doi: 10.1111/dmcn.15139. Epub 2022 Feb 2.PMID: 35112345 Review.

Avoidant/restrictive food intake disorder and autism spectrum disorder: clinical implications for assessment and management.

Farag F, Sims A, Strudwick K, Carrasco J, Waters A, Ford V, Hopkins J, Whitlingum G, Absoud M, Kelly VB.Dev Med Child Neurol. 2022 Feb;64(2):176-182. doi: 10.1111/dmcn.14977. Epub 2021 Aug 17.PMID: 34405406


Cited by

MDMA for the treatment of misophonia, a proposal.

Webb J, Keane S.Front Psychiatry. 2022 Nov 10;13:983285. doi: 10.3389/fpsyt.2022.983285. eCollection 2022.PMID: 36440420 Free PMC article.

Agomelatine Monotherapy for Autism-A Case Report.

Naguy A, Pridmore S, Jamali MA, Hasan AE, Alamiri B.Psychopharmacol Bull. 2022 Oct 27;52(4):100-103.PMID: 36339272

Misophonia: A Systematic Review of Current and Future Trends in This Emerging Clinical Field.

Ferrer-Torres A, Giménez-Llort L.Int J Environ Res Public Health. 2022 Jun 1;19(11):6790. doi: 10.3390/ijerph19116790.PMID: 35682372 Free PMC article. Review.


KMEL References